A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Conditions
Active Immunisation for Chikungunya Virus Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
All India Institute of Medical Sciences, Guwahati, Assam, India
All India Institute of Medical Sciences, Patna, Bihar, India
Contact: Principal Investigator (Sanjay Pandey, MBBS MD)All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Contact: Study coordinator (Abhiruchi Galhotra, MBBS MD) · abhiruchigalhotra@aiimsraipur.edu.in · 8518881711Contact: Principal Investigator (Abhiruchi Galhotra, MBBS MD)Redkar Hospital and Research Centre, Mumbai, Goa, India
Contact: Principal Investigator (Sagar vivek redkar, MBBS MD)PGIMS, Rohtak, Haryana, India
Contact: Principal Investigator (savita verma, MBBS MD)IMS & SUM Hospital bhubaneshwar Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha, India
Contact: Principal Investigator (Venkata Rao Epari, MBBS MD)Jawahar Lal Nehru medical College, Ajmer, Rajasthan, India
Contact: Principal Investigator (Sanjiv Maheshwari, MBBS MD)Sardar Patel Medical College, Bikaner, Rajasthan, India
Contact: Principal Investigator (Veer Bahadur Singh, MBBS MD)Guru Teg Bahadur Hospital, Delhi, The National Capital Territory (nct) of Delhi, India
Contact: Principal Investigator (Shiva Narang, MBBS MD)AIIMS Rishikesh Department of Community Medicine, Rishikesh, Uttarakhand, India
Contact: Principal Investigator (Mahendra Singh, MBBS MD)